VT
VIR icon

Vise Technologies’s Vir Biotechnology VIR Stock Holding History

Vise Technologies’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,861
Closed -$149K – 368
2023
Q3 		$149K Sell
15,861
-17,022
-52% -$243K 0.04% 324
2023
Q2 		$807K Sell
32,883
-1,888
-5% -$47.4K 0.2% 115
2023
Q1 		$809K Buy
34,771
+4,579
+15% +$117K 0.21% 109
2022
Q4 		$764K Buy
30,192
+8,917
+42% +$219K 0.24% 105
2022
Q3 		$410K Sell
21,275
-2,869
-12% -$72.9K 0.15% 160
2022
Q2 		$615K Buy
+24,144
New +$564K 0.24% 104

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Vise Technologies's VIR Position: Q4 2023 in Review

Vise Technologies sold out of Vir Biotechnology (VIR) in Q4 2023, closing a stake of 15,861 shares — an estimated $149K sold.

Vise Technologies first reported a position in VIR in Q2 2022 and held it in 6 quarters. The position peaked at $809K in Q1 2023. 206 funds tracked by Wall St. Rank hold VIR as of Q4 2023.

  • Vise Technologies reported no remaining Vir Biotechnology position as of Q4 2023 after selling out during the quarter.
  • Vise Technologies sold 15,861 Vir Biotechnology shares in Q4 2023, an estimated $149K.
  • Vise Technologies first reported a position in Vir Biotechnology in Q2 2022 and held it in 6 quarters.
  • Vise Technologies's Vir Biotechnology position peaked at $809K in Q1 2023.
  • 206 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2023.

Based on Vise Technologies's 13F filing for Q4 2023, filed 8 Feb 2024.